BAX
Price
$21.91
Change
+$0.21 (+0.97%)
Updated
Sep 26, 12:59 PM (EDT)
Capitalization
11.15B
34 days until earnings call
SOLV
Price
$71.59
Change
+$1.13 (+1.60%)
Updated
Sep 26, 01:28 PM (EDT)
Capitalization
12.22B
41 days until earnings call
Interact to see
Advertisement

BAX vs SOLV

Header iconBAX vs SOLV Comparison
Open Charts BAX vs SOLVBanner chart's image
Baxter International
Price$21.91
Change+$0.21 (+0.97%)
Volume$8.07K
Capitalization11.15B
Solventum
Price$71.59
Change+$1.13 (+1.60%)
Volume$100
Capitalization12.22B
BAX vs SOLV Comparison Chart in %
Loading...
BAX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SOLV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BAX vs. SOLV commentary
Sep 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BAX is a Buy and SOLV is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 26, 2025
Stock price -- (BAX: $21.71 vs. SOLV: $70.46)
Brand notoriety: BAX and SOLV are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: BAX: 92% vs. SOLV: 114%
Market capitalization -- BAX: $11.15B vs. SOLV: $12.22B
BAX [@Pharmaceuticals: Other] is valued at $11.15B. SOLV’s [@Pharmaceuticals: Other] market capitalization is $12.22B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $157.06B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $10.92B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BAX’s FA Score shows that 2 FA rating(s) are green whileSOLV’s FA Score has 0 green FA rating(s).

  • BAX’s FA Score: 2 green, 3 red.
  • SOLV’s FA Score: 0 green, 5 red.
According to our system of comparison, BAX is a better buy in the long-term than SOLV.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BAX’s TA Score shows that 5 TA indicator(s) are bullish while SOLV’s TA Score has 5 bullish TA indicator(s).

  • BAX’s TA Score: 5 bullish, 3 bearish.
  • SOLV’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, BAX is a better buy in the short-term than SOLV.

Price Growth

BAX (@Pharmaceuticals: Other) experienced а -8.36% price change this week, while SOLV (@Pharmaceuticals: Other) price change was -5.26% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -1.30%. For the same industry, the average monthly price growth was -3.33%, and the average quarterly price growth was +8.49%.

Reported Earning Dates

BAX is expected to report earnings on Oct 30, 2025.

SOLV is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-1.30% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SOLV($12.2B) has a higher market cap than BAX($11.2B). BAX has higher P/E ratio than SOLV: BAX (87.85) vs SOLV (32.32). SOLV YTD gains are higher at: 6.661 vs. BAX (-24.242). SOLV has higher annual earnings (EBITDA): 1.28B vs. BAX (1.04B). BAX has more cash in the bank: 1.69B vs. SOLV (492M). SOLV has less debt than BAX: SOLV (7.82B) vs BAX (9.73B). BAX has higher revenues than SOLV: BAX (10.9B) vs SOLV (8.39B).
BAXSOLVBAX / SOLV
Capitalization11.2B12.2B92%
EBITDA1.04B1.28B81%
Gain YTD-24.2426.661-364%
P/E Ratio87.8532.32272%
Revenue10.9B8.39B130%
Total Cash1.69B492M343%
Total Debt9.73B7.82B124%
FUNDAMENTALS RATINGS
BAX: Fundamental Ratings
BAX
OUTLOOK RATING
1..100
55
VALUATION
overvalued / fair valued / undervalued
1..100
18
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
92
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
30
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BAXSOLV
RSI
ODDS (%)
Bullish Trend 2 days ago
61%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
53%
Bullish Trend 2 days ago
60%
Momentum
ODDS (%)
Bearish Trend 2 days ago
66%
Bearish Trend 2 days ago
46%
MACD
ODDS (%)
Bearish Trend 2 days ago
65%
Bearish Trend 2 days ago
64%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
61%
Bearish Trend 2 days ago
53%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
63%
Bearish Trend 2 days ago
59%
Advances
ODDS (%)
Bullish Trend 22 days ago
52%
Bullish Trend 19 days ago
64%
Declines
ODDS (%)
Bearish Trend 2 days ago
60%
Bearish Trend 2 days ago
55%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
55%
Bullish Trend 2 days ago
56%
Aroon
ODDS (%)
Bullish Trend 2 days ago
59%
Bullish Trend 2 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
BAX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SOLV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
KEMQ26.300.08
+0.30%
KraneShares Em Mkts Cnsmr Tech ETF
KMLM26.86-0.07
-0.26%
KraneShares Mount LucasMgdFutsIdxStgyETF
AVIV66.56-0.31
-0.46%
Avantis International Large Cap Val ETF
FV61.21-0.40
-0.64%
First Trust Dorsey Wright Focus 5 ETF
IMST35.11-2.36
-6.30%
Bitwise MSTR Option Income Strategy ETF

BAX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BAX has been closely correlated with ALGN. These tickers have moved in lockstep 68% of the time. This A.I.-generated data suggests there is a high statistical probability that if BAX jumps, then ALGN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BAX
1D Price
Change %
BAX100%
-3.77%
ALGN - BAX
68%
Closely correlated
-2.57%
LUNG - BAX
53%
Loosely correlated
-3.39%
STE - BAX
51%
Loosely correlated
-0.73%
SYK - BAX
51%
Loosely correlated
-0.71%
SOLV - BAX
50%
Loosely correlated
-1.89%
More

SOLV and

Correlation & Price change

A.I.dvisor indicates that over the last year, SOLV has been loosely correlated with NVST. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if SOLV jumps, then NVST could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SOLV
1D Price
Change %
SOLV100%
-1.89%
NVST - SOLV
53%
Loosely correlated
-2.73%
BAX - SOLV
50%
Loosely correlated
-3.77%
RMD - SOLV
48%
Loosely correlated
-2.51%
AZTA - SOLV
48%
Loosely correlated
-3.56%
ALC - SOLV
46%
Loosely correlated
-2.35%
More